Screening for Adrenal Insufficiency During Dermocorticoid Reduction in Bullous Pemphigoid (BP)

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 4, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
Pemphigoid, BullousAdrenal Insufficiency
Interventions
DIAGNOSTIC_TEST

clobetasol decreasing measurement

"At two occasions during the clobetasol decreasing measurement at 8 AM and clinical assessment by a physician:~* Visit 1: 20-40 g clobetasol twice a week for at least 1 month~* Visit 2: 20-40 g clobetasol once a week for at least 1 month"

Trial Locations (5)

33000

RECRUITING

University Hospital of Bordeaux - Hospital Saint André, Bordeaux

33500

RECRUITING

CH de Libourne, Libourne

76000

RECRUITING

CHU de Rouen, Rouen

87000

RECRUITING

CHU de Limoges, Limoges

Unknown

RECRUITING

Hôpital Saint louis, Paris

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER